Cents, I did some DD on the Dendritic Cells, its very complex process. The only company that got FDA clinical approval which was mentioned in yesterday's PR was acquired in 2015 for $495 million by now Bausch Health its 10 billion market cap. (Valeant Pharmaceuticals acquires Dendreon for $495 million)